1. Home
  2. OSIS vs RYTM Comparison

OSIS vs RYTM Comparison

Compare OSIS & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • RYTM
  • Stock Information
  • Founded
  • OSIS 1987
  • RYTM 2008
  • Country
  • OSIS United States
  • RYTM United States
  • Employees
  • OSIS N/A
  • RYTM N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • RYTM Health Care
  • Exchange
  • OSIS Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • OSIS 3.3B
  • RYTM 3.5B
  • IPO Year
  • OSIS 1997
  • RYTM 2017
  • Fundamental
  • Price
  • OSIS $202.27
  • RYTM $56.07
  • Analyst Decision
  • OSIS Strong Buy
  • RYTM Strong Buy
  • Analyst Count
  • OSIS 6
  • RYTM 10
  • Target Price
  • OSIS $205.17
  • RYTM $66.90
  • AVG Volume (30 Days)
  • OSIS 205.6K
  • RYTM 380.5K
  • Earning Date
  • OSIS 01-23-2025
  • RYTM 02-26-2025
  • Dividend Yield
  • OSIS N/A
  • RYTM N/A
  • EPS Growth
  • OSIS 18.05
  • RYTM N/A
  • EPS
  • OSIS 7.78
  • RYTM N/A
  • Revenue
  • OSIS $1,650,140,000.00
  • RYTM $112,530,000.00
  • Revenue This Year
  • OSIS $12.49
  • RYTM $66.58
  • Revenue Next Year
  • OSIS $5.20
  • RYTM $44.63
  • P/E Ratio
  • OSIS $26.07
  • RYTM N/A
  • Revenue Growth
  • OSIS 20.69
  • RYTM 81.55
  • 52 Week Low
  • OSIS $126.57
  • RYTM $35.17
  • 52 Week High
  • OSIS $220.00
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 54.00
  • RYTM 42.18
  • Support Level
  • OSIS $202.71
  • RYTM $56.03
  • Resistance Level
  • OSIS $220.00
  • RYTM $58.65
  • Average True Range (ATR)
  • OSIS 6.98
  • RYTM 1.87
  • MACD
  • OSIS -0.53
  • RYTM -0.27
  • Stochastic Oscillator
  • OSIS 44.54
  • RYTM 5.45

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

Share on Social Networks: